(Q35289603)

English

Clinical and prognostic implications of plasma insulin-like growth factor-1 and vascular endothelial growth factor in patients with hepatocellular carcinoma

scientific article

In more languages

default values for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

7 August 2017

Clinical and prognostic implications of plasma insulin-like growth factor-1 and vascular endothelial growth factor in patients with hepatocellular carcinoma (English)

1 reference

Europe PubMed Central

PubMed publication ID

7 August 2017

0 references

1 reference

based on heuristic

inferred from title

Jean-Nicolas Vauthey

8

object named as

Jean-Nicolas Vauthey

0 references

James Lewis Abbruzzese

11

object named as

James L Abbruzzese

1 reference

Europe PubMed Central

PubMed publication ID

7 August 2017

author name string

Ahmed O Kaseb

1

1 reference

Europe PubMed Central

PubMed publication ID

7 August 2017

Jeffrey S Morris

2

1 reference

Europe PubMed Central

PubMed publication ID

7 August 2017

Manal M Hassan

3

1 reference

Europe PubMed Central

PubMed publication ID

7 August 2017

Adnan M Siddiqui

4

1 reference

Europe PubMed Central

PubMed publication ID

7 August 2017

E Lin

5

1 reference

Europe PubMed Central

PubMed publication ID

7 August 2017

Lianchun Xiao

6

1 reference

Europe PubMed Central

PubMed publication ID

7 August 2017

Eddie K Abdalla

7

1 reference

Europe PubMed Central

PubMed publication ID

7 August 2017

Thomas A Aloia

9

1 reference

Europe PubMed Central

PubMed publication ID

7 August 2017

Sunil Krishnan

10

1 reference

Europe PubMed Central

PubMed publication ID

7 August 2017

language of work or name

0 references

publication date

12 September 2011

1 reference

Europe PubMed Central

PubMed publication ID

7 August 2017

Journal of Clinical Oncology

1 reference

Europe PubMed Central

PubMed publication ID

7 August 2017

29

1 reference

Europe PubMed Central

PubMed publication ID

7 August 2017

29

1 reference

Europe PubMed Central

PubMed publication ID

7 August 2017

3892-3899

1 reference

Europe PubMed Central

PubMed publication ID

7 August 2017

V-CLIP: Integrating plasma vascular endothelial growth factor into a new scoring system to stratify patients with advanced hepatocellular carcinoma for clinical trials

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3189091

27 July 2018

I-CLIP: improved stratification of advanced hepatocellular carcinoma patients by integrating plasma IGF-1 into CLIP score

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3189091

27 July 2018

Advanced hepatocellular carcinoma: which staging systems best predict prognosis?

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3189091

27 July 2018

Design and endpoints of clinical trials in hepatocellular carcinoma.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3189091

27 July 2018

Staging systems in hepatocellular carcinoma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3189091

27 July 2018

Possible contribution of serum activin A and IGF-1 in the development of hepatocellular carcinoma in Egyptian patients suffering from combined hepatitis C virus infection and hepatic schistosomiasis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3189091

27 July 2018

Management of hepatocellular carcinoma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3189091

27 July 2018

Expression of albumin, IGF-1, IGFBP-3 in tumor tissues and adjacent non-tumor tissues of hepatocellular carcinoma patients with cirrhosis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3189091

27 July 2018

Assessment of the prognosis of cirrhosis: Child-Pugh versus MELD.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3189091

27 July 2018

Proposal of a new prognostic model for hepatocellular carcinoma: an analysis of 403 patients

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3189091

27 July 2018

Serum insulin-like growth factor I evaluation as a useful tool for predicting the risk of developing hepatocellular carcinoma in patients with hepatitis C virus-related cirrhosis: a prospective study.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3189091

27 July 2018

Clinical management of hepatocellular carcinoma. Conclusions of the Barcelona-2000 EASL conference. European Association for the Study of the Liver

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3189091

27 July 2018

Prognosis of hepatocellular carcinoma: the BCLC staging classification

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3189091

27 July 2018

Normal growth and development in the absence of hepatic insulin-like growth factor I

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3189091

27 July 2018

Prospective study of colorectal cancer risk in men and plasma levels of insulin-like growth factor (IGF)-I and IGF-binding protein-3.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3189091

27 July 2018

Plasma insulin-like growth factor-I and prostate cancer risk: a prospective study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3189091

27 July 2018

Natural history of hepatocellular carcinoma and prognosis in relation to treatment. Study of 850 patients

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3189091

27 July 2018

The possible autocrine/paracrine and endocrine roles of insulin-like growth factors of human tumors

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3189091

27 July 2018

Pretreatment assessment of hepatocellular cancer: expert consensus conference

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3189091

26 September 2018

Association of circulating insulin-like growth factor 1 with hepatocellular carcinoma: one cross-sectional correlation study.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3189091

26 September 2018

Epidemiology of hepatocellular carcinoma in Hispanics in the United States

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3189091

26 September 2018

Clinical significance of plasma D-dimer levels and serum VEGF levels in patients with hepatocellular carcinoma.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3189091

26 September 2018

Prognostic staging system for hepatocellular carcinoma (CLIP score): its value and limitations, and a proposal for a new staging system, the Japan Integrated Staging Score (JIS score).

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3189091

26 September 2018

Plasma levels of insulin-like growth factor-I and lung cancer risk: a case-control analysis.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3189091

26 September 2018

Prognosis of advanced hepatocellular carcinoma: comparison of three staging systems in two French clinical trials

1 reference

https://pubmed.ncbi.nlm.nih.gov/21911725

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Transcripts of the insulin-like growth factors I and II in human hepatoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/21911725

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Insulin-like growth factor 1 in hepatocellular carcinoma and metastatic liver cancer in men

1 reference

https://pubmed.ncbi.nlm.nih.gov/21911725

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Circulating concentrations of insulin-like growth factor I and risk of breast cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/21911725

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Circulating growth hormone and insulin-like growth factor-I in nonalcoholic liver cirrhosis with or without superimposed hepatocarcinoma: evidence of an altered circadian rhythm

1 reference

https://pubmed.ncbi.nlm.nih.gov/21911725

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Assessment of the clinical significance of serum vascular endothelial growth factor and matrix metalloproteinase-9 in patients with hepatocellular carcinoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/21911725

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

IL-6 and IGF-1 are independent prognostic factors of liver steatosis and non-alcoholic steatohepatitis in morbidly obese patients

1 reference

https://pubmed.ncbi.nlm.nih.gov/21911725

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Quantitative analysis of vascular endothelial growth factor, microvascular density and their clinicopathologic features in human hepatocellular carcinoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/21911725

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Rising incidence of hepatocellular carcinoma in the United States

1 reference

https://pubmed.ncbi.nlm.nih.gov/21911725

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A new prognostic system for hepatocellular carcinoma: A retrospective study of 435 patients

1 reference

https://pubmed.ncbi.nlm.nih.gov/21911725

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Prognostic significance of serum vascular endothelial growth factor and endostatin in patients with hepatocellular carcinoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/21911725

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1200/JCO.2011.36.0636

1 reference

Europe PubMed Central

PubMed publication ID

7 August 2017

PMC publication ID

1 reference

Europe PubMed Central

PubMed publication ID

7 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

7 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q35289603&oldid=1818655861"